What is CYTOF's dilution risk score?

CYTOF currently has a DilutionScore of 41/100, indicating medium dilution risk. DilutionWatch monitors CYTOF SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for CYTOF?

DilutionWatch tracks 25 SEC filing types for CYTOF including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CYTOF shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CYTOF, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CYTOF tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CYTOF. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CYTOF Dilution Risk Score: 41/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

40

📊 Float Risk

12

⚠️ Warrant Exposure

40

🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

27%

🔄 Reverse Split 55%

• 50-day avg $0.07 below $1 exchange minimum

🔔 Track CYTOF — Get forecast alerts →

💹 Market Data

Market Cap$400.1K

Shares Outstanding4.66M

Float4.12M

Cash$3.8K

Debt$523.9K

Short InterestN/A

🏛 Institutional Holdings

2 institutional holders · 2 shares

#1 LRI Investments, LLC 1 shares

#2 DANSKE BANK A/S 1 shares

📉 Short Interest

Short Interest17.3K

Days to Cover1.6

% of Float0.4%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 01, 2020

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CYTOF Shareholders

Altamira Therapeutics Ltd. (CYTOF) has a DilutionScore of 41/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CYTOF shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CYTOF in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CYTOF alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

🔬 More Research for CYTOF

📊 CYTOF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CYTOF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

CYTOF — Altamira Therapeutics Ltd. Dilution Risk Tracker